BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
4 results:

  • 1. [Dynamic monitoring on ovarian function among patients having had cervical squamous cell carcinoma transposition surgery].
    An Y; Qiao Z; Zou M; Yu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jan; 35(1):85-7. PubMed ID: 24685045
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.
    McAlpine JN; Porter H; Köbel M; Nelson BH; Prentice LM; Kalloger SE; Senz J; Milne K; Ding J; Shah SP; Huntsman DG; Gilks CB
    Mod Pathol; 2012 May; 25(5):740-50. PubMed ID: 22282309
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary bilateral ovarian and uterine Burkitt's lymphoma following chemotherapy for breast cancer.
    Hatami M; Whitney K; Goldberg GL
    Arch Gynecol Obstet; 2010 Apr; 281(4):697-702. PubMed ID: 19756677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Potential for cure in ovarian cancer.
    Piver MS; Marchetti DL
    Compr Ther; 1986 Dec; 12(12):13-20. PubMed ID: 3791928
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.